DNA Wellness Private Limited, based in Ahmedabad, is investing Rs 200 crore to build about 100 screening facilities nationwide, marking a major advancement in the nation’s fight against cervical cancer. The British Columbia Cancer Research Agency in Canada has granted the business the rights to perform the cutting-edge DNA Ploidy Test, a ground-breaking method for early cancer detection. Compared to traditional techniques like the pap smear, this test can identify malignant cells up to two years earlier.
By recognizing particular alterations in cells that may result in cancer, the DNA Ploidy Test functions. As a non-invasive method with 100% specificity and 98% sensitivity, it is an extremely dependable early detection technique. In Ahmedabad, the first lab dedicated to cervical cancer screening with this test has already opened, and by October 2024, more facilities in Vadodara, Rajkot, and Surat are expected to open.
About 1.3 lakh new cases and 80,000 deaths from cervical cancer occur each year in India, making it one of the top causes of cancer-related deaths among women. The National Cancer Registry Report 2023 states that 1,800 deaths and 17,000 new cervical cancer diagnoses in Gujarat alone occurred in 2023. The need for more efficient screening and preventative actions is made clear by these numbers.
Gynecologic oncologist Dr. Anjana Chauhan highlighted the value of early detection and said that the DNA Ploidy Test is a major advancement. This test has the ability to identify precancerous alterations early on, allowing for timely intervention and prevention of cervical cancer. This is particularly important because, if detected early on, cervical cancer is both common and preventable.
Long-term HPV (Human Papillomavirus) infections, a compromised immune system, smoking, obesity, and the use of contraceptives are among the risk factors that lead to cervical cancer. Regular screening and HPV vaccination are advised by experts as preventative methods to fight the illness.
Many Gujarati entrepreneurs are introducing novel cervical cancer screening techniques in response to the rising incidence of the disease. For example, the M-Strip device, a self-sampling kit for cervical cancer diagnosis, was created by Ahmedabad-based IOTA Diagnostic. Cervi Check, situated in Vadodara, offers a similar self-sampling kit that enables women to gather samples in a discreet and safe manner for early detection.
With early detection essential to lowering mortality and enhancing outcomes for women, these initiatives mark a significant advancement in the fight against cervical cancer in India.
SOURCE :
TIMES OF INDIA
